Showing 1-3 of 3 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Diamyd® to Preserve Endogenous Beta Cell Function in Adolescents and Adults with Recently Diagnosed Type 1 Diabetes, Carrying the Genetic HLA DR3-DQ2 Haplotype | Diamyd Medical | Ulf Hannelius | Cures | 01-April-2023 to 31-March-2028 | $6,750,000.00 |
| The Effect of Roxadustat on Renal Oxygenation in Diabetes Nephropathy (FOXTROT) | Karolinska Institutet | Sergiu Catrina | Improving Lives | 01-August-2026 to 31-July-2029 | $1,011,737.00 |
| PRIME: Protective Regenerative Islet Microenvironment Engineering | Karolinska Institutet | Dimitri Van Simaeys | Cures | 01-October-2026 to 30-September-2029 | $900,000.00 |